CIK: 0002013341 · Show all filings
Period: Q4 2024 (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $224,422 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | 2,221,474 | $63,712 | 28.4% | $34.21 | 0.0% | COM | 156944100 |
| ALMS | Alumis Inc | 4,202,670 | $33,033 | 14.7% | $10.02 | 0.0% | COM | 022307102 |
| CNTA | Centessa Pharmaceuticals Inc | 1,253,379 | $20,994 | 9.4% | $16.75 | — | SPONSORED ADS | 152309100 |
| — | Rapt Therapeutics Inc | 12,500,000 | $19,750 | 8.8% | $1.58 | — | COM | 75382E109 |
| BCAX | Bicara Therapeutics Inc | 950,000 | $16,549 | 7.4% | $20.81 | 0.0% | COM | 055477103 |
| EWTX | Edgewise Therapeutics Inc | 585,000 | $15,620 | 7.0% | $31.84 | 0.0% | COM | 28036F105 |
| GPCR | Structure Therapeutics Inc | 420,000 | $11,390 | 5.1% | $27.12 | — | SPONSORED ADS | 86366E106 |
| — | Akero Therapeutics Inc | 365,000 | $10,154 | 4.5% | $27.82 | — | COM | 00973Y108 |
| CRVS | Corvus Pharmaceuticals Inc | 1,581,233 | $8,460 | 3.8% | $7.47 | 0.0% | COM | 221015100 |
| CGEM | Cullinan Therapeutics Inc | 634,558 | $7,729 | 3.4% | $14.37 | 0.0% | COM | 230031106 |
| ALLO | Allogene Therapeutics Inc | 3,448,275 | $7,345 | 3.3% | $2.47 | 0.0% | COM | 019770106 |
| KYMR | Kymera Therapeutics Inc | 146,332 | $5,887 | 2.6% | $45.17 | 0.0% | COM | 501575104 |
| CASIF | Casi Pharmaceuticals Inc | 1,329,383 | $3,762 | 1.7% | $4.74 | 0.0% | ORD SHS | G1933S101 |
| VRDN | Viridian Therapeutics, Inc | 1,974 | $38 | 0.0% | $21.74 | 0.0% | COM | 92790C104 |